|
1
|
Rothlin RP, Pelorosso F, Duarte M, Nicolosi L, Fernandez Criado I, Salgado MV, Vetulli H. RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one. Rev Port Cardiol 2024; 43:219-220. [PMID: 37940073 DOI: 10.1016/j.repc.2023.08.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 08/11/2023] [Indexed: 11/10/2023] Open
Affiliation(s)
- Rodolfo P Rothlin
- Sociedad Argentina de Farmacología Clínica, Asociación Médica Argentina, Argentina.
| | - Facundo Pelorosso
- Servicio de Anatomía Patológica, Hospital de Alta Complejidad El Calafate SAMIC, Argentina
| | - Mariano Duarte
- Laboratorio de Hipertensión, División de Cardiología, Hospital de Clínicas «José de San Martín», Facultad de Medicina, Universidad de Buenos Aires, Argentina; Segunda Cátedra de Fisiología, Facultad de Medicina, Universidad de Buenos Aires, Argentina
| | - Liliana Nicolosi
- División de Cardiología, Hospital Español de Buenos Aires, Argentina
| | - Ignacio Fernandez Criado
- Sección de Tecnología Educativa e Informática Médica, Hospital de Clínicas «José de San Martín», Facultad de Medicina, Universidad de Buenos Aires, Argentina
| | - María Victoria Salgado
- Centro de Estudios de Estado y Sociedad, Ciudad Autónoma de Buenos Aires, Argentina; Servicio de Medicina Familiar, Hospital de Alta Complejidad El Calafate SAMIC, Argentina
| | - Héctor Vetulli
- Servicio de Electrofisiología Cardíaca, Arritmias y Marcapasos, Sanatorio Otamendi y Miroli, Ciudad Autónoma de Buenos Aires, Argentina
| |
Collapse
|
|
2
|
Gonçalves J, Santos CD, Fresco P, Fernandez-Llimos F. Reply to: RAAS inhibitors in COVID-19: Not all are created equal. Telmisartan is the one. Rev Port Cardiol 2024; 43:221-222. [PMID: 37918782 DOI: 10.1016/j.repc.2023.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2023] [Accepted: 10/30/2023] [Indexed: 11/04/2023] Open
Affiliation(s)
- Jorge Gonçalves
- Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal.
| | - Catarina D Santos
- Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
| | - Paula Fresco
- Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
| | - Fernando Fernandez-Llimos
- Laboratório de Farmacologia, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal; Mechanistic Pharmacology and Pharmacotherapy Unit, UCIBIO-i4HB, Faculty of Pharmacy, University of Porto, Porto, Portugal
| |
Collapse
|